Q2 2025 Holdings
Filed 2025-08-14 | 65 holdings | $542.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $39.0M | 741,972 | 7.2% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $38.1M | 713,811 | 7.0% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $33.9M | 358,297 | 6.2% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $27.7M | 2,022,482 | 5.1% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $25.3M | 400,772 | 4.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $25.1M | 249,060 | 4.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $20.7M | 1,832,171 | 3.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $20.5M | 162,969 | 3.8% |
| Merus N VCall | CALL | N5749R900 | $20.1M | 382,500 | 3.7% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $20.0M | 2,037,087 | 3.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $18.3M | 1,800,829 | 3.4% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $18.0M | 235,583 | 3.3% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $17.1M | 204,591 | 3.2% |
| Spdr Series TrustCall | CALL | 78464A900 | $16.6M | 200,000 | 3.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $14.9M | 86,552 | 2.8% |
| CG Oncology Inc(CGON) | COM | 156944100 | $14.1M | 541,034 | 2.6% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $12.1M | 448,495 | 2.2% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $12.1M | 341,010 | 2.2% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $11.6M | 410,000 | 2.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $9.4M | 287,796 | 1.7% |
| Pfizer Inc(PFE) | COM | 717081103 | $8.3M | 344,338 | 1.5% |
| Nuvalent IncCall | CALL | 670703907 | $7.6M | 100,200 | 1.4% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $6.5M | 613,393 | 1.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $6.3M | 5,146,782 | 1.2% |
| Metsera Inc | COM | 59267L107 | $5.9M | 207,581 | 1.1% |
| Elutia Inc(ELUT) | CL A COM | 05479K106 | $5.5M | 2,761,684 | 1.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $5.4M | 3,033,879 | 1.0% |
| Tela BIO Inc(TELA) | COM | 872381108 | $5.4M | 2,779,795 | 1.0% |
| Abeona Therapeutics Inc(ABEO) | COM NEW | 00289Y206 | $5.2M | 917,898 | 1.0% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $5.1M | 103,943 | 0.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $4.0M | 198,441 | 0.7% |
| Aardvark Therapeutics Inc(AARD) | COM | 002942100 | $3.9M | 286,807 | 0.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $3.9M | 82,023 | 0.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.8M | 402,964 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $3.6M | 175,636 | 0.7% |
| Cogent Communications HldgsCall | CALL | 19239V902 | $3.6M | 500,000 | 0.7% |
| Cerus Corp(CERS) | COM | 157085101 | $3.5M | 2,488,291 | 0.6% |
| Erasca Inc(ERAS) | COM | 29479A108 | $3.3M | 2,569,591 | 0.6% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $3.2M | 1,249,781 | 0.6% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $3.2M | 186,015 | 0.6% |
| Benitec Biopharma Inc(BNTC) | COM NEW | 08205P209 | $3.0M | 253,234 | 0.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $3.0M | 539,587 | 0.5% |
| Uniqure NV(QURE) | SHS | N90064101 | $2.8M | 202,565 | 0.5% |
| Hims & Hers Health IncPut | PUT | 433000956 | $2.5M | 50,000 | 0.5% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $2.1M | 75,959 | 0.4% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $1.9M | 165,389 | 0.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $1.8M | 95,806 | 0.3% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $1.7M | 109,257 | 0.3% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $1.6M | 115,282 | 0.3% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $1.5M | 401,540 | 0.3% |